GPX Embolic Device Success in Challenging Tumor Case

SALT LAKE CITY, Jan. 20, 2022 /PRNewswire/ — Fluidx Medical’s GPX Embolic Device was used to effectively devascularize a large tumor with multiple feeding vessels as part of a multi-center clinical trial. “This could have been a challenging case since it involved a large renal tumor fed…

About the Author

has written 41562 stories on this site.

Copyright © 2010 Business and Corporate News.